Vertex Pharmaceuticals Inc
VRTX· Nasdaq
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q1 2010 | Q1 2009 |
|---|---|---|
| Revenue | $22.43M | $23.98M |
| Net Income | -$165.27M | -$162.67M |
| EPS Diluted | -$0.83 | -$1.04 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Vertex Pharmaceuticals Inc · CIK 875320 · Engraved from SEC EDGAR